Biotech Articles Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame Keywords July 27, 2026 7:55 AM ETInnovative ETF Strategies That Are Paying Off This SummerNathan ReiffNYSEARCA:BBCNASDAQ:FMEDNYSE:VRead Innovative ETF Strategies That Are Paying Off This SummerJuly 13, 2026 10:25 AM ETThe Phase 3 Failure That Sent Biotech Winners and Losers in Opposite DirectionsJeffrey Neal JohnsonNYSE:AZNNASDAQ:IONSNASDAQ:BBIORead The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite DirectionsJuly 8, 2026 7:05 AM ETVertex’s Crinetics Deal Balances Growth with Integration RiskChris MarkochNASDAQ:VRTXNASDAQ:CRNXRead Vertex’s Crinetics Deal Balances Growth with Integration RiskJuly 7, 2026 10:25 AM ETAbivax: Wall Street Catches Up to the DataChris MarkochNASDAQ:ABVXNYSE:ABBVRead Abivax: Wall Street Catches Up to the DataJuly 1, 2026 5:00 AM ETShort Squeeze Alert—Moderna Stock Surges on New StrategyChris MarkochNASDAQ:MRNARead Short Squeeze Alert—Moderna Stock Surges on New StrategyJune 29, 2026 7:20 AM ET5 Places Investors Can Hide If the AI Trade Keeps CrackingRyan HassonNASDAQ:IBBNYSEARCA:XLINYSEARCA:XLURead 5 Places Investors Can Hide If the AI Trade Keeps CrackingJune 23, 2026 9:50 AM ETThe Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch.Ryan HassonNASDAQ:IBBRead The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch.June 21, 2026 8:30 AM ET3 Biotech Firms With Major Potential Catalysts in the Coming MonthsNathan ReiffNASDAQ:KRYSNASDAQ:ADMANASDAQ:VERARead 3 Biotech Firms With Major Potential Catalysts in the Coming MonthsJune 20, 2026 7:20 AM ET3 Penny Stocks Under $5 Backed by Real Revenue GrowthChris MarkochNYSEAMERICAN:URGNASDAQ:ACRSNASDAQ:GRABRead 3 Penny Stocks Under $5 Backed by Real Revenue GrowthJune 11, 2026 10:25 AM ETPatent Cliff Predators: GSK Acquires Nuvalent For $10.6 BillionJeffrey Neal JohnsonNASDAQ:NUVLNYSE:GSKNYSE:PFERead Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 BillionJune 8, 2026 5:40 AM ET3 Longevity ETFs to Buy and Hold (and Hold)Nathan ReiffNYSEARCA:XBINYSEARCA:BMEDNASDAQ:AGNGRead 3 Longevity ETFs to Buy and Hold (and Hold)June 7, 2026 6:45 AM ET3 ETFs For the Coming Genomics RevolutionNathan ReiffBATS:ARKGBATS:HELXNYSEARCA:IDNARead 3 ETFs For the Coming Genomics RevolutionJune 4, 2026 8:50 AM ETBefore the IPO: 4 Companies That Rewarded Investors Who Got In EarlyBridget BennettNYSEAMERICAN:FJETNYSE:BUDNASDAQ:CNXURead Before the IPO: 4 Companies That Rewarded Investors Who Got In EarlyMay 28, 2026 9:00 AM ETIs Co-Diagnostics National Security’s Next Diagnostic Pick?Jeffrey Neal JohnsonNASDAQ:OSURNASDAQ:CODXNASDAQ:GOVXRead Is Co-Diagnostics National Security’s Next Diagnostic Pick?May 24, 2026 6:50 AM ETAmylyx Stock: Why the Full Pipeline Story MattersChris MarkochNASDAQ:AMLXNASDAQ:REGNNYSE:MRKRead Amylyx Stock: Why the Full Pipeline Story MattersMay 23, 2026 5:50 AM ETKiniksa Pharmaceuticals Still Has Room to Run After 100% RallyChris MarkochNASDAQ:KNSARead Kiniksa Pharmaceuticals Still Has Room to Run After 100% RallyMay 22, 2026 5:50 AM ETBiogen Stock Slides After Trial Miss, But Analysts Stay BullishChris MarkochNASDAQ:BIIBNASDAQ:APLSRead Biogen Stock Slides After Trial Miss, But Analysts Stay BullishMay 20, 2026 12:55 PM ETFrom Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 OutlookLeo MillerNYSE:LLYNYSE:NVORead From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 OutlookMay 20, 2026 10:35 AM ETMirum Pharma: A Rare Disease Growth Story to WatchChris MarkochNASDAQ:MIRMRead Mirum Pharma: A Rare Disease Growth Story to WatchMay 15, 2026 5:05 AM ET2 Ways to Play the Big Pharma Patent CliffNathan ReiffNYSEARCA:XBINASDAQ:IBBNYSE:PFERead 2 Ways to Play the Big Pharma Patent CliffMay 7, 2026 8:05 AM ETWhat the FDA's Latest Proposal Means for Lilly, Novo, and HimsLeo MillerNYSE:LLYNYSE:NVONYSE:HIMSRead What the FDA's Latest Proposal Means for Lilly, Novo, and HimsMay 2, 2026 6:45 AM ETThe Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the BeatJessica MitacekNYSE:ABBVNYSE:AZNNYSE:GSKRead The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the BeatMay 1, 2026 11:05 AM ETLilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentNathan ReiffNYSE:LLYNYSE:NVORead Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentMay 1, 2026 8:45 AM ETViking Therapeutics Faces Timeline Risk—But Upside Could Be HugeChris MarkochNASDAQ:VKTXNYSE:LLYNYSE:NVORead Viking Therapeutics Faces Timeline Risk—But Upside Could Be HugeApril 29, 2026 12:50 PM ETAbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?Thomas HughesNYSE:ABBVNYSE:ABTRead AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead? More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCommunication Services SectorCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingInvestor EducationIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsReal Estate SectorSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorUtilities SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.